ERYTECH Pharma S.A. Short Interest Down 60.1 percent in May
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Slightly above 62% of Erytech Pharma's investor base is looking to short. The analysis of current outlook of investing in Erytech Pharma SA suggests that many traders are alarmed regarding Erytech Pharma's prospects. Erytech Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Erytech Pharma SA. Many technical investors use Erytech Pharma SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Erytech |
ERYTECH Pharma S.A. was the target of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 37,900 shares, a decrease of 60.1 percent from the May 15th total of 95,000 shares. Based on an average daily volume of 139,400 shares, the days-to-cover ratio is
Read at thelincolnianonline.com
 |
Erytech Pharma Fundamental Analysis
We analyze Erytech Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Erytech Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Erytech Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Erytech Pharma is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Erytech Pharma SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Erytech Pharma stock to make a market-neutral strategy. Peer analysis of Erytech Pharma could also be used in its relative valuation, which is a method of valuing Erytech Pharma by comparing valuation metrics with similar companies.
Peers
Erytech Pharma Related Equities
| APM | Aptorum Group | 30.77 | ||||
| HCWB | HCW Biologics | 8.51 | ||||
| UNCY | Unicycive Therapeutics | 7.25 | ||||
| XRTX | XORTX Therapeutics | 4.72 | ||||
| SNGX | Soligenix | 0.90 | ||||
| ELYM | Eliem Therapeutics | 0.31 | ||||
| IKNA | Ikena Oncology | 1.16 | ||||
| GNFT | Genfit | 3.80 | ||||
| ADXN | Addex Therapeutics | 4.02 | ||||
| ARMP | Armata Pharmaceuticals | 4.35 | ||||
| NTRB | Nutriband | 5.21 | ||||
| SRZN | Surrozen | 6.80 | ||||
| MOLN | Molecular Partners | 7.22 | ||||
| ATXI | Avenue Therapeutics | 9.77 | ||||
| XCUR | Exicure | 24.38 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |